Will vaccines sound the death knell for Sweden’s Covid experiment?
Herd immunity will require fewer sacrifices if it can be achieved with an effective vaccination programme
Back in March, as Sweden embarked on a uniquely open approach to the coronavirus pandemic - and its death toll began to rise - state epidemiologist Anders Tegnell (pictured) urged the rest of the world to reserve judgement.
“In the autumn there will be a second wave,” he said. “Sweden will have a high level of immunity and the number of cases will probably be quite low.”
For a time, it looked as if he might be vindicated. In September, the Swedish policy of keeping the economy open while asking people to reduce social interaction was “beginning to gain traction elsewhere in Europe”, The National reported.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sweden was recording fewer than 300 new cases of Covid-19 per day, “compared with thousands in other European countries such as Britain, France and Spain”, the paper adds. “Its average number of deaths [was] one a day.” And Swedes had benefited from the business-as-usual approach to schooling, socialising and health services.
As autumn turns to winter, however, the calculus has changed again. Cases are on the rise and more people are dying in Sweden than in its Nordic neighbours (although Sweden’s current mortality rate is below Germany’s and less than a tenth of Belgium’s).
The big shift, though, is the promise that herd immunity might soon be achieved through artificial means.
“As half a dozen vaccines draw into sight,” says The Times, “it is at last possible to set down the rudiments of a meaningful judgment on the strategy.” And Swedish critics of their country’s approach “believe it is finally clear that their country has paid far too high a price for too few tangible results”, the paper reports.
Even Tegnell himself seems to be having second thoughts. “Throughout history there has up to now been no infectious disease whose transmission was fully halted by herd immunity without a vaccine,” he recently told the German newspaper Der Spiegel.
Fortunately for Swedes - and the rest of us - we won’t have to find out if Covid-19 could have been the first.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published